,
Farrugia, Lynn A.
Rhyee, Sean H.
Calello, Diane P.
Campleman, Sharan L.
Riederer, Anne M.
Malashock, Hannah R.
Pizon, Anthony
Wiegand, Timothy
Wax, Paul M.
Brent, Jeffrey
Funding for this research was provided by:
National Institute on Drug Abuse (1R56DA38366)
National Institute on Drug Abuse (1R01DA037317-01)
U.S. Food and Drug Administration
BTG International Inc.
Article History
Received: 30 June 2017
Revised: 17 July 2017
Accepted: 18 July 2017
First Online: 1 August 2017
Compliance with Ethical Standards
:
: ToxIC was supported by a continuation of a grant from the US National Institutes of Health on cardiovascular drug toxicity, a new contract with the US Food and Drug Administration, and the continuation of unrestricted grant support from BTG International, which was used to support the North American Snakebite Registry.
: None
: None
: This study received funding from the NIH National Institute on Drug Abuse 1R56DA38366, and 1R01DA037317-01, a data sharing contract with the U.S. Food and Drug Administration, and BTG International Inc.